What are the goals of drug treatment for acquired nystagmus?

Updated: Oct 17, 2018
  • Author: Christopher M Bardorf, MD, MS; Chief Editor: Edsel Ing, MD, MPH, FRCSC  more...
  • Print

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

The potassium channel blocker 3,4-diaminopyridine has been suggested as an off-label treatment for downbeat nystagmus. [1, 20]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!